The unmethylated status of the CpG islands is important for gene expression of correlated housekeeping genes since it is well known that their methylation inhibits transcription process. An interesting question that has been discussed but not solved is how the CpG islands maintain their characteristic unmethylated status even though they are rich in CpG dinucleotides. Our previous in vitro and in vivo research has shown that poly(ADP-ribosyl)ation is involved in protecting CpG dinucleotides from full methylation in genomic DNA and that a block of poly(ADP-ribosyl)ation is also involved in modifying the methylation pattern in the promoter region of Htf9 housekeeping gene. In this study we locked for cytological evidence that in the absence of an active poly(ADP-ribosyl)ation the DNA methylation pattern in L929 and NIH/3T3 mouse fibroblast cell lines is altered. For this purpose, differences in the methylation levels of interphase nuclei from control and treated cultures of two murine cell lines preincubated with 2 mM 3-aminobenzamide, an inhibitor of poly(ADP-ribosyl)ation, were measured in individual cells after indirect immunolabeling with anti-5MeC antibodies. The quantitative analysis allowed us to demonstrate that blocking of the poly(ADP-ribosyl)ation results in a higher number, size, and density of antibody binding regions in treated cells when compared to the controls. Analogously, sequential Giemsa staining and indirect immunolabeling of the same slides showed the heterochromatic regions colocalized with the extended methyl-rich domains.
The role played by a consecutive series of DNA modifications in human cancer cells is being progressively uncovered. A mutator phenotype causing the observed higher rates of spontaneous mutations may be required for genomic instability and the onset of multistep carcinogenesis (1, 2). Hypermethylation of tumor suppressor genes and/or hypomethylation of specific growthpromoting proto-oncogenes may contribute to the selective advantage of neoplastic cells and thus represent one of the steps involved in the onset of malignancy. Hypomethylation of proto-oncogenes was observed in liver tumors and leukemias (3). In several reports reduced levels of global DNA methylation in tumor cell populations were described (3, 4). Hypomethylation has been found to be positively correlated with both malignant transformation and tumor progression (4). We have recently developed a computer-assisted method (5) based on the indirect immunolabeling by anti-5-MeC antibodies (6) to quantify eu-and heterochromatin methylation in individual nuclei. The reliability of the quantitative approach in the evaluation of methylation levels is further confirmed by the good agreement of molecular and cytological results obtained in experimentally hypermethylated mouse cell cultures (7).In the present report experiments were set up to assess the application of such technology to human primary lymphocyte subsets. Two sets of cytospins were prepared from Lymphoprep (Nycomed Pharma AS, Oslo, Norway) separated mononuclear cells of three normal individuals following removal of adherent cells. For each donor, in one set of cytospins the CLB-BLY1 (CD22) monoclonal antibody (Ortho Diagnostics, Raritan, NJ) was used to detect B cells, and in the other the UCHT1 (CD3) monoclonal antibody (Dako, Glostrup, Denmark) was used to recognize T lymphocytes. The immunocytochemical reaction was performed with the immunoperoxidase technique using Dako reagents as previously described (7). Diaminobenzidine (DAB, Sigma, Milan, Italy), which gave a deep brown staining of the labeled cells, was used as the substrate.All slides were then exposed to UV light for DNA denaturation, followed by indirect immunolabeling with the monoclonal anti-5-MeC antibodies (8) and subse-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.